Chronic Graft versus Host Disease

Common Name(s)

Chronic Graft versus Host Disease

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chronic Graft versus Host Disease" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chronic Graft versus Host Disease" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Chronic Graft versus Host Disease" returned 435 free, full-text research articles on human participants. First 3 results:

Chronic Graft-versus-host Disease Presenting with Multiple Punctate Intracranial Lesions on Contrast-enhanced Magnetic Resonance Imaging.
 

Author(s): Makoto Terada, Kiyotaka Nakamagoe, Naoshi Obara, Shinichi Ogawa, Noriaki Sakamoto, Taiki Sato, Seitaro Nohara, Shigeru Chiba, Akira Tamaoka

Journal: Intern. Med.. 2017 ;56(3):363-368.

 

Central nervous system graft-versus-host disease can present quite a diagnostic challenge. We herein present a case of histologically-confirmed chronic graft versus host disease (GVHD) involving the central nervous system that occurred at 19 months after peripheral blood stem cell ...

Last Updated: 3 Feb 2017

Go To URL
Phase I/IIa Study of Low Dose Subcutaneous Interleukin-2 (IL-2) for Treatment of Refractory Chronic Graft Versus Host Disease.
 

Author(s): Takeru Asano, Ken-Ichi Matsuoka, Satoshi Iyama, Kazuteru Ohashi, Yoshihiro Inamoto, Chikako Ohwada, Makoto Murata, Atsushi Satake, Chikamasa Yoshida, Koichi Nakase, Yasuo Mori, Mitsune Tanimoto

Journal: Acta Med. Okayama. 2016 Oct;70(5):429-433.

 

Chronic graft versus host disease (cGVHD) remains a major problem for long survivors after allogeneic hematopoietic stem cell transplantation (HSCT). Currently, corticosteroid therapy is effective for cGVHD as the first line therapy. However, prolonged therapy with corticosteroids ...

Last Updated: 25 Oct 2016

Go To URL
An Open-labeled, Multicenter Phase II Study of Tamibarotene in Patients with Steroid-refractory Chronic Graft-versus-Host Disease.
 

Author(s): Yoshinobu Maeda, Hisakazu Nishimori, Yoshihiro Inamoto, Hirohisa Nakamae, Masashi Sawa, Yasuo Mori, Kazuteru Ohashi, Shin-Ichiro Fujiwara, Mitsune Tanimoto

Journal: Acta Med. Okayama. 2016 Oct;70(5):409-412.

 

Chronic graft-versus-host disease (GVHD) is a major cause of late death and morbidity following allogeneic hematopoietic cell transplantation (HSCT). Retinoic acid (tamibarotene) exerts multiple effects on cell differentiation and is clinically used for the treatment of acute promyelocytic ...

Last Updated: 25 Oct 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Chronic Graft versus Host Disease" returned 51 free, full-text review articles on human participants. First 3 results:

Cytokine mediators of chronic graft-versus-host disease.
 

Author(s): Kelli Pa MacDonald, Bruce R Blazar, Geoffrey R Hill

Journal: J. Clin. Invest.. 2017 Jun;127(7):2452-2463.

 

Substantial preclinical and clinical research into chronic graft-versus-host disease (cGVHD) has come to fruition in the last five years, generating a clear understanding of a complex cytokine-driven cellular network. cGVHD is mediated by naive T cells differentiating within IL-17-secreting ...

Last Updated: 30 Jun 2017

Go To URL
Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation.
 

Author(s): Vaneuza A M Funke, Maria Claudia Rodrigues Moreira, Afonso Celso Vigorito

Journal: Rev Assoc Med Bras (1992). 2016 Oct;62 SupplĀ 1():44-50.

 

graft-versus-host disease (GVHD) is one of the main complications of hematopoietic stem cell transplantation, affecting about 50% to 80% of the patients. Acute GVHD and its clinical manifestations are discussed in this article, as well as the new NIH criteria for the diagnosis and ...

Last Updated: 16 Dec 2016

Go To URL
Hosting an Unruly Guest: The Impact of Late Acute and Chronic Graft-versus-Host Disease.
 

Author(s): Michael Byrne, Bipin N Savani

Journal: Biol. Blood Marrow Transplant.. 2016 May;22(5):779-80.

 

Last Updated: 8 Apr 2016

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells
 

Status: Recruiting

Condition Summary: Chronic Graft-Versus-Host Disease

 

Last Updated: 11 Nov 2014

Go to URL

Last Updated: 30 Jun 2017

Go to URL